Cancer glossary
The FOLFOX regimen: what it contains, how a cycle works and what to expect
FOLFOX is a chemotherapy regimen of oxaliplatin, fluorouracil and leucovorin. Which cancers it treats, how the 14-day cycle works, why a pump is used and which side effects occur.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
FOLFOX is one of the most common chemotherapy regimens for colon and rectal cancer. The name comes from its drugs: FOLinic acid (leucovorin), Fluorouracil and OXaliplatin.
How it appears in your prescription
- ‘mFOLFOX6 every 14 days’ — the most common version: oxaliplatin and leucovorin by drip, fluorouracil as a push and then by pump for 46 hours.
- ‘FOLFOX + bevacizumab’ or ‘+ cetuximab/panitumumab’ — in metastatic cancer, depending on KRAS and tumor side.
- ‘FOLFOX × 12 cycles (6 months) / 3 months adjuvant’ — after surgery.
What it means
According to the US National Cancer Institute, FOLFOX is used in colorectal cancer — after surgery and for metastatic disease — and in stomach, esophageal and other gastrointestinal cancers. Leucovorin doesn't kill the tumor itself: it strengthens fluorouracil. A port is almost always needed for the long infusion.
Side effects
The main one is neuropathy from oxaliplatin: acute cold sensitivity in the first days after the infusion and cumulative numbness in the fingers over time. Also nausea, diarrhea, mouth sores, low neutrophils and platelets, and fatigue.
Questions to ask your doctor
- How many cycles are planned, and what will decide when to stop?
- If the numbness in my fingers gets worse, will oxaliplatin be dropped?
- Was I tested for DPD deficiency before fluorouracil?
Sources
- FOLFOX — National Cancer Institute
- Oxaliplatin — National Cancer Institute
- Fluorouracil Injection — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
